Replies to post #782013 on NorthWest Biotherapeutics Inc (NWBO)

[theorysuit]

Facts and filings. What BS.

Facts and filings outweigh recycled talking points.

It is 7 years since this trial ended, how many approvals? #facts.
How many cdmos have shareholders funded for the ceo?

[RobotDroid]

Your tired paid pumper playbook always ignores the fact that Linda grifter is a mute inept sleazeball and has a clown crew of nonworking nonmanagement that all pay themselves well. To see the problem, look in the mirror. Can you use cabal in more sentences please?

[Investor082]

Look at you! You have been pumping the same BS for many years. $30+ share price prediction for many years, ignore the reality and dilution, LOL! Share price lost over 80% since your non-stop pumps 4-5 years ago.

LP just diluted at .22. Just let that sink in while the data lock happened over 5 years ago, TLD presentation happened around 3.5 years ago, JAMA around 3 years ago, MAA approaching 2 years. Yet no one is interested in this company. The last financier thought it was worth .22. The next financing will be in teens (.19 or less).

[HyGro]

It's not validated until there is approval. FDA rejected it and they are the ones that REALLY count. Virtually every clinician that endorsed it made money as a trial site. The rest are just seeing the :processed" trial data from a Totally redone protocol done when the trial was virtually completed. That's making up the rules after the game is already played. UK approval, if it ever occurs, is not going to make NWBO and the poor shareholders much money because NICE won't pay for personalized oncology therapies. NWBO hasn't even made ANY moves to commercialize DCVax-L. Deep in debt, only getting money from vulture funds that feed on failing OTC biotechs. Sad to watch the steady decline of the share price -- investment community isn't buying it.